Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, PLW

Medicx Media Solutions Issued First U.S. Patent


SCOTTSDALE, Ariz., April 18, 2019 /PRNewswire/ -- Medicx Media Solutions (https://medicxmedia.com), the leading U.S. data-driven healthcare media analytics company, today announced the issuance of U.S. Patent No. 10,262,761 to Founder & CEO Michael Weintraub for his technical invention of the apparatus and methods for the delivery of advertising based on the prevalence of a healthcare condition in hyper-local geographic areas across the U.S.

To learn more about Medicx Media Solutions, visit: https://medicxmedia.com/approach/

The patent relates to the company's Micro-Neighborhood® targeting platform that includes:

"After more than ten years of continued success, recognition on this level further confirms the uniqueness, relevance and power of the Medicx Micro-Neighborhood® targeting platform. This patent proves that the granularity of our data and the ability to customize our audience segments with near precision, in a HIPAA compliant manner, delivers far more efficient and effective campaign outcomes with stronger ROI. That is why we are the market leaders," said Medicx Founder & CEO Michael Weintraub.

About Medicx Media Solutions
Medicx Media Solutions (https://medicxmedia.com/) is the premier data-driven healthcare media analytics company that sets the standard for hyper-locally targeted multichannel marketing and media campaigns with a focus on life sciences and other health-related brands. Through a patented analytical and HIPAA-compliant1 Micro-Neighborhood® targeting approach, Medicx creates hyper-local, multichannel marketing and media campaigns. Medicx tracks 35MM+ Micro-Neighborhoods®, encompassing 240MM+ adult patients and over 4MM healthcare practitioners. The result is an unmatched method of locating and engaging the right audiences across multiple platforms and channels resulting in more efficient and effective use of our client's media dollars, higher audience quality and compelling ROIs.

¹A re-identification risk determination was performed pursuant to the HIPAA Privacy Rule Expert Determination standard and the determination concluded that, in the given data use and disclosure context, the risk of re-identification was very small.

 

Medicx Tagline Logo (PRNewsfoto/Medicx Media Solutions)

 

SOURCE Medicx Media Solutions


These press releases may also interest you

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...



News published on and distributed by: